XBI Smaller-Cap Biotech ETF Looking Higher
|XBI (Generally, the Smaller Cap Biotech ETF) has been and still is in a well-defined up-channel since Nov. 2016. Within the dominant bullish channel, XBI is circling the upper third of the channel as it pauses in its upward traverse from the lower channel boundary (89.00) to the upper channel boundary (104).
From a nearer term perspective, as long as XBI weakness is contained in and around today's low at 95.20/00, the pattern argues for higher, into the area of the upper channel boundary at 104. However, a break below 95.00 will inflict meaningful near term technical damage that will point XBI towards 92-90 thereafter. Last is 96.97/98.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.